Consequently, hypercholesterolemic male Apoe−/− mice already subjected to four weeks of Ang II infusion (and therefore harboring AAAs), were treated for two weeks with RXP470.1 (Figure 4A). The gene discussed is APOE; the disease is achalasia-alacrima syndrome.